iRhythm Technologies, Inc. (IRTC) financial statements (2021 and earlier)

Company profile

Business Address 650 TOWNSEND STREET
SAN FRANCISCO, CA 94103
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:14178102111
Cash and cash equivalents2020952
Short-term investments120589454
Other undisclosed cash, cash equivalents, and short-term investments   5
Restricted cash and investments   0
Receivables2422139
Inventory, net of allowances, customer advances and progress billings4221
Inventory4221
Other undisclosed current assets443(4)
Total current assets:173106120119
Noncurrent Assets
Operating lease, right-of-use asset90
Property, plant and equipment26965
Long-term investments and receivables8 311
Long-term investments8 311
Intangible assets, net (including goodwill)1111
Goodwill1111
Other noncurrent assets8333
Total noncurrent assets:133131420
TOTAL ASSETS:306120133138
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities41291812
Accounts payable8222
Accrued liabilities33271610
Interest and dividends payable000 
Deferred revenue1
Debt2 1 
Deferred revenue and credits11
Contract with customer, liability1
Other undisclosed current liabilities8   
Total current liabilities:52302113
Noncurrent Liabilities
Long-term debt and lease obligation86353232
Long-term debt, excluding current maturities 353232
Operating lease, liability86
Liabilities, other than long-term debt 000
Deferred revenue and credits00
Deferred rent credit 0
Other undisclosed noncurrent liabilities33  0
Total noncurrent liabilities:119353332
Total liabilities:171655446
Stockholders' equity
Stockholders' equity attributable to parent135548093
Common stock0000
Additional paid in capital396258236220
Accumulated other comprehensive income (loss)0(0)(0)(0)
Accumulated deficit(260)(204)(157)(127)
Total stockholders' equity:135548093
TOTAL LIABILITIES AND EQUITY:306120133138

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues2151479964
Revenue, net9964
Cost of revenue(52)(39)(28)(21)
Gross profit:1621097143
Operating expenses(217)(152)(98)(59)
Operating loss:(55)(44)(27)(16)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
221(2)
Interest and debt expense(2)(6)(3)(3)
Loss from continuing operations before income taxes:(55)(48)(29)(21)
Income tax expense(0)(0)  
Net loss available to common stockholders, diluted:(55)(48)(29)(21)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net loss:(55)(48)(29)(21)
Comprehensive loss:(55)(48)(29)(21)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent00(0)(0)
Comprehensive loss, net of tax, attributable to parent:(54)(48)(29)(21)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: